Koi Research Labs expands peptide distribution in the U.S. and Canada

Koi Research Labs said it has added separate in-country fulfillment operations in the United States and Canada to speed delivery of research-use-only peptides and keep inventory COA-verified. The move does not change the products’ regulatory status or remove import and use obligations in either country.

Why it matters: - Researchers in the United States and Canada can now receive domestic shipments of research-grade peptides through separate national fulfillment networks. - The setup is designed to shorten transit times, reduce customs delays, and preserve product stability with faster in-country delivery. - The change improves logistics for laboratory buyers, but it does not alter the products’ research-use-only status.

What happened: - Koi Research Labs expanded research peptide distribution across the USA and Canada on June 8, 2026. - The company now operates separate in-country fulfillment in each market. - Material does not cross the U.S.-Canada border in either direction. - Researchers in the U.S. receive shipments through the U.S. fulfillment network. - Researchers in Canada receive shipments through the Canadian fulfillment network.

The details: - Every lot shipped in either market is HPLC purity verified and mass spectrometry identity confirmed. - Each vial carries a batch number that matches a lot-specific Certificate of Analysis. - The company said cold-chain handling is used where stability profiles require it. - Lyophilized material ships in moisture-barrier packaging. - Domestic peptide delivery within each country is typically 2 to 5 business days, depending on destination and shipping option. - The company said international sourcing can add transit time and customs detention risk. - U.S. Customs and Border Protection and the Canada Border Services Agency screen unapproved peptide shipments at their borders. - Material held at customs can face longer ambient exposure, which matters for lyophilized peptide stability. - Koi Research Labs also said its catalog includes bacterial endotoxin testing and lot-specific COAs tied to synthesis batch numbers. - The company lists U.S. ordering information and Canada ordering information on its websites.

Between the lines: - The expansion is a logistics move, not a regulatory change. - Koi Research Labs said the two-market model keeps the same analytical standard in both countries while avoiding cross-border shipping. - The structure may appeal to researchers who need faster access and more predictable handling, especially for temperature-sensitive material. - The company also said RUO labeling is not an import exemption or a use exemption in either country.

What’s next: - Koi Research Labs will continue operating parallel domestic supply chains for the U.S. and Canada. - Researchers can expect the same documentation and release standards across both markets. - Regulatory obligations under the FD&C Act in the United States and the Food and Drugs Act in Canada remain in place.

The bottom line: - Koi Research Labs is using in-country fulfillment to speed delivery of research-only peptides in the U.S. and Canada without changing the products’ legal status.